Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting &bgr;-amyloid peptide release and/or its synthesis by use of such compounds
US6506782B1 · kind B1 · utility
17Cited by
0References
53Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 27, 1998 |
| Grant date | Jan 14, 2003 |
| Priority date | — |
| Expiry date | Feb 27, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/4245
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.